New Bubbleroom Sweden AB (publ) (STO:BBROOM)
13.90
0.00 (0.00%)
Sep 2, 2026, 5:18 PM CET
New Bubbleroom Sweden AB Revenue
New Bubbleroom Sweden AB had revenue of 146.62M SEK in the quarter ending June 30, 2026, with 15.73% growth. This brings the company's revenue in the last twelve months to 445.50M, up 2.28% year-over-year. In the year 2025, New Bubbleroom Sweden AB had annual revenue of 426.45M, down -3.04%.
Revenue (ttm)
445.50M
Revenue Growth
+2.28%
P/S Ratio
0.49
Revenue / Employee
7.50M
Employees
59
Market Cap
216.09M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 426.45M | -13.35M | -3.04% |
| Dec 31, 2024 | 439.80M | 13.58M | 3.19% |
| Dec 31, 2023 | 426.22M | -17.21M | -3.88% |
| Dec 31, 2022 | 443.43M | 32.68M | 7.96% |
| Dec 31, 2021 | 410.75M | 24.54M | 6.35% |
| Dec 31, 2020 | 386.21M | -42.32M | -9.88% |
| Dec 31, 2019 | 428.53M | 140.56M | 48.81% |
| Dec 31, 2018 | 287.97M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BHG Group AB | 10.91B |
| Meds Apotek AB | 1.08B |
| Desenio Group AB | 703.10M |
| Guldbrev Holding AB | 500.40M |
| CDON AB | 457.00M |
| Vuxen Group AB | 245.70M |
| Vetted Assets AB | 157.73M |
New Bubbleroom Sweden AB News
- 7 weeks ago - New Bubbleroom Sweden AB Quarterly report: Q2 2026 - Filings
- 7 weeks ago - New Bubbleroom Sweden AB Slides: Q2 2026 - Filings
- 4 months ago - New Bubbleroom Sweden AB Quarterly report: Q1 2026 - Filings
- 4 months ago - New Bubbleroom Sweden AB Slides: Q1 2026 - Filings
- 6 months ago - New Bubbleroom Sweden AB Quarterly report: Q4 2025 - Filings
- 6 months ago - New Bubbleroom Sweden AB Slides: Q4 2025 - Filings
- 6 months ago - New Bubbleroom Sweden AB Annual report: Q4 2025 - Filings
- 10 months ago - New Bubbleroom Sweden AB Quarterly report: Q3 2025 - Filings